Max Robotics — Global Service Robot Directory + US Certification

About

Matteo Parrinello is a pioneering cardiac surgeon at the forefront of robotic-assisted heart surgery. His research centers on advancing minimally invasive and hybrid approaches for complex cardiac conditions, particularly atrial fibrillation and mitral valve disease. Dr. Parrinello’s major contributions include demonstrating the feasibility and safety of the robotic-enhanced hybrid convergent procedure for persistent atrial fibrillation, as documented in his first European experience (12 citations). He has also rigorously analyzed the learning curve for robotic mitral valve repair, incorporating the disruptive impact of the COVID-19 pandemic (9 citations), and provided early evidence that robotic-assisted mitral surgery yields comparable or superior early postoperative outcomes to traditional minimally invasive techniques. His work extends to cost-effectiveness analyses, showing that the higher upfront cost of robotic surgery can be offset by clinical advantages. With a growing portfolio of studies on postoperative risk stratification and enhanced recovery protocols, Dr. Parrinello is shaping the next generation of cardiac surgical care. His recent investigations into functional conduction gaps and atrial fibrosis as predictors of arrhythmia recurrence after hybrid ablation represent a critical step toward personalizing treatment for persistent atrial fibrillation.